Neurocrine Bio. (NBIX) PT Raised to $87 at SVB Leerink
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $145.35 --0%
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 13 | New: 3
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 13 | New: 3
Join SI Premium – FREE
SVB Leerink analyst Marc Goodman raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $87.00 (from $84.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird Reiterates Outperform Rating on Neurocrine Bio. (NBIX)
- Shyam Metalics & Energy (SHYAMMET:IN) PT Raised to INR1,299 at ICICI Securities
- Finolex Industries Ltd. (FNXP:IN) PT Lowered to INR190 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
